Vascularized Atrial Cardiac Organoid

  • Vascularized Atrial Cardiac Organoid

Human iPSC-derived Vascularized Atrial Cardiac Organoid

These organoids combine atrial cardiomyocytes with integrated vascular networks, enhancing physiological relevance and providing a robust platform for modeling atrial-specific diseases, drug testing, and tissue engineering applications.

Benefits

  • Atrial-specific cardiac physiology with vascularization
  • Enhanced organoid maturation and long-term viability
  • Ideal for atrial fibrillation and cardiac drug safety studies

Product Specifications

Feature

Detail

Identity Markers

Atrial markers (MLC2a, NPPA) + endothelial markers (CD31, VE-Cadherin)

Quantities

≥ 1 × 10⁶ cells per vascularized organoid

Quality Control

Atrial electrophysiology, vascular network staining, mycoplasma testing

Format

Cryopreserved vascularized organoids

Donor & Reprogramming

Healthy donor; Sendai virus reprogramming

Shipping / Storage

Dry shipper at -180°C to -135°C

Supplied with

Culture medium and instructions

Explore Vascularized Atrial Cardiac Organoid

Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.

Our Products